openPR Logo
Press release

Allergic Conjunctivitis - Pipeline Review, H2 2016

11-24-2016 03:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Allergic Conjunctivitis

MarketResearchReports.Biz presents this most up-to-date research on "Allergic Conjunctivitis - Pipeline Review, H2 2016"

Description

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis Pipeline Review, H2 2016, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape.

Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) become swollen or inflamed due to a reaction to pollen, dander, mold, or other allergy-causing substances. Symptoms include intense itching, puffy eyelids, widened (dilated) vessels in the clear tissue covering the white of the eye and stringy eye discharge. Treatment includes antihistamine or anti-inflammatory medication.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Allergic Conjunctivitis Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Allergic Conjunctivitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 1, 1, 8 and 1 respectively for Allergic Conjunctivitis.

Allergic Conjunctivitis (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/862949

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Allergic Conjunctivitis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Allergic Conjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Allergic Conjunctivitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Allergic Conjunctivitis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Allergic Conjunctivitis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Browse Latest Industry Press Release at: http://www.marketresearchreports.biz/pressreleases

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Contact
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergic Conjunctivitis - Pipeline Review, H2 2016 here

News-ID: 386848 • Views: 555

More Releases for Ophthalmology

Lighting the Future of Ophthalmology
28th International Conference on Insights in Ophthalmology April 18 - 19, 2019 Rome, Italy Ophthalmology is the branch of medicine which deals with the treatment, disorders & diseases related to the eye. It is mainly deals with the functions of the eye and how the way they should be treats the eye diseases. All tests that profess to diagnose the eye diseases should be carried out by a Medical Practitioner known as an
Euro Ophthalmology 2019
The 2nd European Congress on Ophthalmology going to be held amid March 21-22, 2018 at Amsterdam, The Netherlands, which unites a one of a kind and worldwide blend of substantial and medium pharmaceutical, biotech and symptomatic or diagnostic organizations, leading universities and clinical research companies making the meeting an ideal stage to share understanding, encourage coordinated efforts crosswise over industry and the scholarly community, and assess rising advancements over the
Ophthalmology Devices Market Prevalent Opportunities upto 2020
Ophthalmology is the branch of medicines which deals with anatomy, physiology and diseases of the eye. Some of the major eye diseases include haloes, distorted vision, eyelid abnormalities, glaucoma, retinal disease and cataract. The ophthalmology device market is categorized based on various diagnostic and monitoring devices, surgical devices and vision care products. These segments comprise several devices used for treatment of eye diseases. The diagnostic and monitoring device segment is
Growth Opportunities Of Ophthalmology Therapeutics Market 2017
Albany, NY, 4th December : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way" globally. The visual system, including the eye and its surrounding structures, can be affected by a number of pathological conditions. Ophthalmology encompasses a diverse range of indications affecting
Ophthalmology Devices Sales Global Market Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Global Ophthalmology Devices Sales Market Report 2017”. In this report, the global Ophthalmology Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1254850 Geographically, this report split
Ophthalmology Drug Development Pipeline Review, 2016
ReportsWorldwide has announced the addition of a new report title Ophthalmology Drug Development Pipeline Review, 2016 to its growing collection of premium market research reports. Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, and particularly blindness, can arise. Although there are a number of treatments approved in ophthalmology, there are currently no curative therapies for any of these indications. In